Federal and Regulatory Outreach
AMRPA Comments on CMS ICR Internal Criteria and Audit Protocol
November 12, 2024
Medicare Advantage Prior Authorization Regulatory
AMRPA Comments on CMS Proposed Service Level Data Collection for MA Plans
October 8, 2024
Medicare Advantage Prior Authorization Regulatory
AMRPA Comments on Request for Information on Medicare Advantage Data
May 31, 2024
Medicare Advantage Prior Authorization Regulatory
AMRPA Comments on CY 2025 Medicare Advantage Proposed Rule
January 5, 2024
Medicare Advantage Prior Authorization Regulatory
AMRPA Sign-On Letter to Request Sub-Regulatory Guidance on CY2024 MA Rule
December 6, 2023
Medicare Advantage Prior Authorization Regulatory
AMRPA Comments on Senate HELP Committee on AI in Healthcare
September 22, 2023
Legislative Medicare Advantage Prior Authorization
AMRPA Submits Comments for Congressional Hearing on MA Denials and Delays
June 2, 2023
Legislative Medicare Advantage Prior Authorization
AMRPA Comment Letter re: CY 2024 Policy and Technical Changes to MA Program Proposed Rule
February 14, 2023
Medicare Advantage Prior Authorization Regulatory
AMRPA Response to CMS MA RFI on Health Equity & Access Issues in the Medicare Advantage Program
September 1, 2022
Medicare Advantage Prior Authorization Regulatory
Report: Medicare Advantage Prior Authorization
March 8, 2022
Medicare Advantage Prior Authorization
Response to CMS Request for Information on Prior Authorization
March 8, 2022
Medicare Advantage Prior Authorization Regulatory
AMRPA Comments on CY 2026 MA Proposed Rule